Amgen Inc. (AMGN)

NASDAQ: AMGN · Real-Time Price · USD

460.42

+0.14 (0.03%)

At close: Nov 6, 2026, 4:00 PM EST

459.47

-0.95 (-0.21%)

After-hours: Nov 6, 2026, 7:59 PM EST

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Sep '26 Sep 30, 2026	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021	Jun '21 Jun 30, 2021	Mar '21 Mar 31, 2021	Dec '20 Dec 31, 2020
Prolia Revenue	632.00M
ENBREL Revenue	611.00M
XGEVA Revenue	288.00M
Repatha Revenue	1.09B
Otezla Revenue	481.00M
TEPEZZA Revenue	526.00M
EVENITY Revenue	751.00M
KYPROLIS Revenue	330.00M
Nplate Revenue	472.00M
Aranesp Revenue	329.00M
BLINCYTO Revenue	496.00M
KRYSTEXXA Revenue	419.00M
Vectibix Revenue	335.00M
TEZSPIRE Revenue	538.00M
Other Products Revenue	2.59B
Product Revenue	9.88B
Other Revenue	482.00M
Revenue (Total)	10.37B